Skip to content

Study for ideal blood pressure level in perithrombolytic period of acute ischemic stroke

Study for ideal blood pressure level in perithrombolytic period of acute ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026478
Enrollment
Unknown
Registered
2019-10-12
Start date
2015-01-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Case series:intravenous injection of alteplase

Sponsors

The Affiliated Lianyungang Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnosed as acute ischemic stroke according to the relevant standards in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2014; (2) Conforms to the thrombolysis criteria of alteplase in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2014 and receive intravenous thrombolysis within 4.5 h from the onset; (3) There is clear neurological deficit, and NIHSS>1; (4) The patient or the patient's legally authorized agent gave informed consent.

Exclusion criteria

Exclusion criteria: (1) Receive other intravascular treatment such as arterial thrombolysis or mechanical thrombectomy; (2) mRS > 0 before onset; (3) Complicated with severe mental disorder or dementia; (4) Suffering from severe systemic disease and expected survival 80 U/L or previous severe liver disease; (6) Creatinine clearance <30 mL/min or previous severe kidney disease.

Design outcomes

Primary

MeasureTime frame
Blood pressure;

Countries

China

Contacts

Public ContactMingli He

The Affiliated Lianyungang Hospital of Xuzhou Medical University

lyghml@163.com+86 18961326515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026